Join this ECHO Lessons from Leaders webinar, featuring Dr. Carla Spina (CEO & Co-Founder of Noa Therapeutics), who will share an overview of Noa Therapeutics, its technologies, and the story behind its success.

Noa Therapeutics is developing transformative therapies for inflammatory and immune-mediated diseases through a proprietary biased approach to AhR, a validated master regulator of innate immunity and barrier homeostasis whose therapeutic potential has not been fully realized due to historical safety challenges. By precisely biasing AhR signalling, Noa is creating a new class of targeted, non-immunosuppressive treatments designed to deliver durable remission of inflammation and fundamentally reshape outcomes for patients with immune and inflammatory conditions.